Detalhe da pesquisa
1.
Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure.
Int Wound J
; 6(1): 67-72, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19291119
2.
Pharmacotherapy Pearls in Rheumatology for the Care of Older Adult Patients: Focus on Oral Disease-Modifying Antirheumatic Drugs and the Newest Small Molecule Inhibitors.
Rheum Dis Clin North Am
; 44(3): 371-391, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30001781
3.
Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation.
Int Wound J
; 4(4): 333-43, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17953679
4.
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction.
BMC Clin Pharmacol
; 5: 5, 2005 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-16262910
5.
Pulmonary aspergillosis presenting with recurrent haemoptysis.
BMJ Case Rep
; 20152015 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26153296
6.
Angiographic patency study of an albumin-free recombinant streptokinase formulation in acute myocardial infarction.
J Pharm Pharm Sci
; 7(3): 372-7, 2004 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-15576019
7.
Sarcoidosis Concomitant With Takayasu Arteritis, Identified by Advanced Molecular Imaging.
Arthritis Rheumatol
; 71(6): 990, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30714676
8.
Streptokinase for the treatment of acute ischaemic stroke : towards better strategies.
CNS Drugs
; 17(5): 371, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12665394
9.
Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients.
J Thromb Thrombolysis
; 21(2): 185-90, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16622616
10.
Recombinant streptokinase: evidences from clinical use.
Eur Heart J
; 26(14): 1448-9; author reply 1449-50, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15905301